Skip to main navigation Skip to search Skip to main content

Molecular profiling: a case of zbtb16-rara acute promyelocytic leukemia

  • Stephen E. Langabeer
  • , Lisa Preston
  • , Johanna Kelly
  • , Matt Goodyer
  • , Ezzat Elhassadi
  • , Amjad Hayat

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Abstract

Several variant RARA translocations have been reported in acute promyelocytic leukemia (APL) of which the t(11;17)(q23;q21), which results in a ZBTB16-RARA fusion, is the most widely identified and is largely resistant to therapy with all-trans retinoic acid (ATRA). The clinical course together with the cytogenetic and molecular characterization of a case of ATRA-unresponsive ZBTB16-RARA APL is described. Additional mutations potentially cooperating with the translocation fusion product in leukemogenesis have been hitherto unreported in ZBTB16-RARA APL and were sought by application of a next-generation sequencing approach to detect those recurrently found inmyeloid malignancies. This technique identified a solitary, low level mutation in the CEBPA gene. Molecular profiling of additional mutations may provide a platform to individualise therapeutic management in patients with this rare form of APL.
Original languageEnglish (Ireland)
JournalCase Reports in Hematology
DOIs
Publication statusPublished - 1 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • c/ebp-alpha
  • cells
  • complete remission
  • disease
  • Externally hosted open access publications with University of Galway authors
  • genes
  • mutations
  • patient
  • rearrangements
  • trans-retinoic acid

Fingerprint

Dive into the research topics of 'Molecular profiling: a case of zbtb16-rara acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this